Mankind Pharma Q2 Results
- BSE: 543904
- NSE: MANKIND
- ISIN: INE634S01028
- Sector: -
BSE
2,628
76.45 (3.00%)
76.45 (3.00%)Volume9.32 K
Updated: Mon 25 Nov, 2024 | 15:29:25
NSE
2,62573.40 (2.88%)
73.40 (2.88%)Volume6.94 L
Updated: Mon 25 Nov, 2024 | 15:29:59
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q2 Results Highlights
- Total Income₹3,076.51 Cr.(6.33%)
- Operating Profit₹744.42 Cr.(29.69%)
- Profit After Tax₹653.47 Cr.(21.80%)
- Operating Margin24.20%(11.79%)
Note: Comparison is on YoY basis
Quarterly - Mankind Pharma Q2 Results
*All figures in crores except per share values
| Fiscal Period | Sep 24 | Jun 23 | QoQ Comp | Sep 23 | YoY Comp |
|---|---|---|---|---|---|
| Total Revenue | 3,076.51 | 2,578.62 | -% | 2,708.10 | -% |
| Selling/ General/ Admin Expenses Total | 646.43 | 552.91 | -% | 571.96 | -% |
| Depreciation/ Amortization | 105.62 | 87.35 | -% | 96.48 | -% |
| Other Operating Expenses Total | 705.15 | 550.93 | -% | 628.63 | -% |
| Total Operating Expense | 2,332.09 | 2,011.16 | -% | 2,121.94 | -% |
| Operating Income | 744.42 | 567.46 | -% | 586.16 | -% |
| Net Income Before Taxes | 849.32 | 624.47 | -% | 640.99 | -% |
| Net Income | 653.47 | 486.87 | -% | 501.03 | -% |
| Diluted Normalized EPS | 16.28 | 12.15 | -% | 12.49 | -% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
- Markets
01NTPC Green Energy IPO allotment date likely today. GMP, how to check status online
2 min read07:58 AM IST - Markets
02Buy or sell: Sumeet Bagadia recommends three stocks to buy on Monday — Nov 25
4 min read06:15 AM IST - Markets
03Enviro Infra Engineers IPO day 2: GMP jumps; subscription status, review, apply or not?
3 min read03:07 PM IST